In non-small cell lung cancer (NSCLC) cell lines, stimulation with HLA-G fusion protein increases ILT4 expression and activates the extracellular signal-regulated kinase (ERK) signaling pathway. Here, LILRB2 is linked to non-small cell lung carcinoma.